The Sybil prophecy: Searching for predictors of response to bevacizumab in glioblastoma.

Offi, Martina; Gabriele, Lucia; Romagnoli, Giulia; Lauretti, Liverana; Pallini, Roberto; D'Alessandris, Quintino Giorgio

Offi, Martina; Gabriele, Lucia; Romagnoli, Giulia; Lauretti, Liverana; Pallini, Roberto; D'Alessandris, Quintino Giorgio.

Afiliación

Offi M; Department of Neuroscience, Catholic University School of Medicine, Italy.
Gabriele L; Department of Neurosurgery, Fondazione Policlinico Gemelli IRCCS, Italy.
Romagnoli G; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Lauretti L; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Pallini R; Department of Neuroscience, Catholic University School of Medicine, Italy.
D'Alessandris QG; Department of Neurosurgery, Fondazione Policlinico Gemelli IRCCS, Italy.

Neuro Oncol ; 26(8): 1538-1539, 2024 Aug 05.

Article en En | MEDLINE | ID: mdl-38885219

Asunto(s)

Bevacizumab; Neoplasias Encefálicas; Glioblastoma; Glioblastoma/tratamiento farmacológico; Glioblastoma/patología; Humanos; Bevacizumab/uso terapéutico; Neoplasias Encefálicas/tratamiento farmacológico; Antineoplásicos Inmunológicos/uso terapéutico; Pronóstico; Inhibidores de la Angiogénesis/uso terapéutico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Encefálicas / Glioblastoma / Bevacizumab Límite: Humans Idioma: En Revista: Neuro Oncol / Neuro oncol / Neuro-oncology Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google